Advertisement

A

Agilent Technologies, Inc.

Healthcare · USD

Set alert

Price alert · A

All alert types
174.87 USD -6.28 -3.47%
As of Oct 30, 2026 Extended hours 171.27 -2.06%
Bid
174.78 × 100
Ask
174.93 × 400
173.38 Day range 180.80
110.24 52-week range 181.48
YTD
+28.51%
1 year
+21.98%
Open
180.98
Prev close
181.15
Mkt cap
49.30B
Vol
2.76M
Avg vol
2.22M
EPS
5.07
P/E
34.49
Div yield
0.56%
More statistics
Low
173.38
High
180.80
Forward P/E
26.06
Beta
1.21
Short ratio
2.03
Inst. own
95.41%
Dividend
1.02
Ex-div date
Oct 5, 2026
Earnings
Nov 23, 2026
50-d avg
163.72
200-d avg
135.91
1y target
182.05

5D chart

Chart tools
Interval
A five-day price chart173.4175.8178.2180.6183.0Oct 26Oct 27Oct 28Oct 29Oct 30

Key statistics

Market cap
49.44B
Enterprise value
53.46B
Trailing P/E
34.59
Forward P/E
26.06
PEG ratio
1.53
Price / sales
6.71
Price / book
6.72
EPS (TTM)
5.07
Beta
1.21
Dividend yield
0.56%
Payout ratio
19.98%
Profit margin
19.53%
Revenue (TTM)
7.37B
Revenue growth
8.10%
Free cash flow
1.06B
Total cash
1.76B
Total debt
4.15B
Return on equity
20.97%
Shares outstanding
281.97M
Short % of float
2.03%
50-day average
163.72
200-day average
135.91

Analyst view

Consensus: buy

Buy
Price target (mean) 182.05 +4.1% upside
Target (low)
155.00
Target (mean)
182.05
Target (high)
200.00
Ratings (0m) 22 15 buy · 7 hold · 0 sell
  • Strong buy3
  • Buy12
  • Hold7
  • Sell0
  • Strong sell0

Next earnings

Nov 23, 2026

Expected Nov 23, 2026. Consensus EPS estimate 1.73.

Earnings history

Financials — quick view

All financials
A Revenue — quarterly 1.88B
2022-Q4 20222023-Q1 20222023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20232024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20242025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20252026-Q2 20262026-Q3 2026
A Net income — quarterly 362.00M
2022-Q4 20222023-Q1 20222023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20232024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20242025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20252026-Q2 20262026-Q3 2026
A EPS — quarterly 1.28
2022-Q4 20222023-Q1 20222023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20232024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20242025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20252026-Q2 20262026-Q3 2026

Earnings

A recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Nov 23, 2026Oct 31, 20261.72———
Aug 26, 2026Jul 31, 20261.491.62+0.13+8.72%
May 27, 2026Apr 30, 20261.411.49+0.08+5.67%
Feb 25, 2026Jan 31, 20261.371.36-0.01-0.73%
Nov 24, 2025Oct 31, 20251.581.59+0.01+0.36%
Aug 27, 2025Jul 31, 20251.371.370.000.00%

Upgrades / downgrades

A analyst upgrades and downgrades
DateFirmActionFromTo
Oct 26, 2026Deutsche Bankinit—Buy
Oct 13, 2026TD CowenmainBuyBuy
Oct 13, 2026Morgan StanleymainOverweightOverweight
Oct 7, 2026BarclaysmainOverweightOverweight
Aug 28, 2026Wells FargomainOverweightOverweight
Aug 27, 2026StifelmainBuyBuy

About Agilent Technologies, Inc.

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates through three segments: Life Sciences and Diagnostics Markets, Agilent CrossLab, and Applied Markets. The Life Sciences and Diagnostics Markets segment offers liquid chromatography systems and components; and liquid chromatography mass spectrometry systems. This segment is also involved in the genomics, contract development and manufacturing organization, pathology, companion diagnostics, and biomolecular analysis businesses. The Agilent CrossLab segment provides various services, including repairs, parts, maintenance, installations, training, compliance support, software as a service, asset management, consulting, and other custom services. This segment also offers consumables, including gas chromatography and liquid chromatography columns, sample preparation products, custom chemistries, and various laboratory supplies; software and informatics solutions comprising software for instrument control, data acquisition, data analysis, secure storage of results, and laboratory information and workflow management; and OpenLab laboratory software, an open software platform that enables customers to capture, analyze, and share scientific data throughout the lab and across the enterprise. In addition, it provides automated sample preparation solutions, such as liquid handling, plate management, consumables, and scheduling software. The Applied Markets segment offers products in the areas of gas chromatography, mass spectrometry, spectroscopy, vacuum technology, and remarketed instruments. It markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.

Sector
Healthcare
Industry
Diagnostics & Research
Country
United States
Website
agilent.com

News

Your note

Sign in to keep a note on A — it syncs with the Stock Master app.

Insider holders

A insider holders
InsiderRelationLatest transactionDateShares held
ANCHER JENSEN HENRIKOfficerStock Award(Grant)Nov 26, 202490,674
FIELDS-KUNZ HEIDIDirectorStock Award(Grant)Mar 13, 20250
GONSALVES RODNEYOfficerStock GiftNov 25, 20250
KOH BOON HWEEDirectorStock Award(Grant)Mar 18, 202663,184
MCDONNELL PADRAIGChief Executive OfficerStock Award(Grant)Nov 17, 202569,028
MCMAHON ROBERT WChief Financial OfficerStock Award(Grant)Mar 4, 2025172,191

Institution ownership

A institution ownership
Holder% heldSharesValueReported
Blackrock Inc.9.08%25,599,0014.49BJun 29, 2026
Vanguard Capital Management LLC6.54%18,449,8613.24BJun 29, 2026
Vanguard Portfolio Management LLC5.12%14,442,4412.53BJun 29, 2026
State Street Corporation4.56%12,854,2302.25BJun 29, 2026
Massachusetts Financial Services Co.3.55%10,010,8671.76BJun 29, 2026
T. Rowe Price Investment Management, Inc.2.75%7,756,9211.36BJun 29, 2026

Fund ownership

A fund ownership
Holder% heldSharesValueReported
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund3.18%8,960,7771.57BJun 29, 2026
VANGUARD INDEX FUNDS-Vanguard 500 Index Fund2.60%7,323,3571.28BJun 29, 2026
VANGUARD INDEX FUNDS-Vanguard Mid-Cap Index Fund2.17%6,115,3781.07BJun 29, 2026
T. Rowe Price Mid-Cap Growth Fund, Inc.1.46%4,107,878720.32MJun 29, 2026
VANGUARD SPECIALIZED FUNDS-Vanguard Health Care Fund1.46%4,119,810722.41MJul 30, 2026
iShares Trust-iShares Core S&P 500 ETF1.33%3,763,584659.94MSep 29, 2026
Advertisement